Literature DB >> 31072459

Respiratory disorders in patients with omphalocele.

Eileen Duggan1, Pramod S Puligandla2.   

Abstract

The respiratory difficulties experienced by infants with omphalocele are being appreciated with greater frequency. These problems represent self-limited difficulties related to omphalocele closure or are the result of severe pulmonary disease including pulmonary hypoplasia and pulmonary hypertension. Infants with giant omphalocele represent a unique group that may experience increased respiratory morbidity which may lead to chronic respiratory problems extending into childhood and adolescence. Importantly, respiratory insufficiency at birth is an independent predictor of mortality for patients with omphalocele. In this review, we will provide a summary of the respiratory difficulties experienced by patients with omphalocele as well as insight into management and surveillance.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Omphalocele; Pulmonary hypertension; Pulmonary hypoplasia; Respiratory insufficiency

Mesh:

Year:  2019        PMID: 31072459     DOI: 10.1053/j.sempedsurg.2019.04.008

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  4 in total

Review 1.  Abdominal wall defects.

Authors:  Christina M Bence; Amy J Wagner
Journal:  Transl Pediatr       Date:  2021-05

2.  Giant omphalocele associated pulmonary hypertension: A retrospective study.

Authors:  Tai-Xiang Liu; Li-Zhong Du; Xiao-Lu Ma; Zheng Chen; Li-Ping Shi
Journal:  Front Pediatr       Date:  2022-09-09       Impact factor: 3.569

Review 3.  Major abdominal wall defects in the low- and middle-income setting: current status and priorities.

Authors:  Lofty-John Chukwuemeka Anyanwu; Niyi Ade-Ajayi; Udo Rolle
Journal:  Pediatr Surg Int       Date:  2020-03-21       Impact factor: 1.827

4.  Management of Giant Omphalocele Leading to Early Fascial Closure.

Authors:  Mustafa Erman Dörterler
Journal:  Cureus       Date:  2019-10-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.